Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection
Status:
Not yet recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Interventional, single arm, single-centre trial to evaluate the effectiveness and safety of
fecal microbiota therapy (FMT) in the investigators population.